TY - JOUR
T1 - Identifying outcomes reported in trials of interventions in venous leg ulceration for a core outcome set development
T2 - A scoping review
AU - Hallas, Sarah
AU - Nelson, E. Andrea
AU - O'Meara, Susan
AU - Gethin, Georgina
N1 - Publisher Copyright:
© 2022 Tissue Viability Society / Society of Tissue Viability
PY - 2022/11
Y1 - 2022/11
N2 - Background: Venous leg ulceration is a chronic, recurring, condition causing significant patient morbidity. Randomised controlled trials evaluating treatments for venous leg ulceration provide evidence for clinical decision-making. For trial findings to be useful, outcomes measured need to be clinically meaningful, and consistently and fully reported across trials. A core outcome set is an agreed and standardised set of outcomes which should be, as a minimum, reported in all trials for a given indication. Aim: To identify the outcome domains and outcomes reported in trials of interventions for venous leg ulceration. Methods: A scoping review of the literature was carried out. Randomised controlled trials within Cochrane systematic reviews looking at venous leg ulceration interventions and qualitative studies exploring venous leg ulceration were included. Results: The review identified 807 outcomes from randomised controlled trials and 15 outcomes from qualitative studies, and these were grouped into 11 outcome domains: healing, patient reported symptoms, clinician reported symptoms, carer reported symptoms, life impacts, clinical signs, clinical measurement, performance of the intervention, resource use (supplies and clinician time) and adverse events. The outcome domain ‘healing’ included 111 outcomes, ‘symptoms’ 109, ‘life impacts’ 30, ‘clinical signs’ 88, ‘clinical measurement’ 184, ‘performance of the intervention’ 58, ‘resource use’ 52 and ‘adverse events’ 190. Conclusion: The scoping review identified a large number of outcomes (n = 822) across 11 related outcome domains, supporting the need for a core outcome set.
AB - Background: Venous leg ulceration is a chronic, recurring, condition causing significant patient morbidity. Randomised controlled trials evaluating treatments for venous leg ulceration provide evidence for clinical decision-making. For trial findings to be useful, outcomes measured need to be clinically meaningful, and consistently and fully reported across trials. A core outcome set is an agreed and standardised set of outcomes which should be, as a minimum, reported in all trials for a given indication. Aim: To identify the outcome domains and outcomes reported in trials of interventions for venous leg ulceration. Methods: A scoping review of the literature was carried out. Randomised controlled trials within Cochrane systematic reviews looking at venous leg ulceration interventions and qualitative studies exploring venous leg ulceration were included. Results: The review identified 807 outcomes from randomised controlled trials and 15 outcomes from qualitative studies, and these were grouped into 11 outcome domains: healing, patient reported symptoms, clinician reported symptoms, carer reported symptoms, life impacts, clinical signs, clinical measurement, performance of the intervention, resource use (supplies and clinician time) and adverse events. The outcome domain ‘healing’ included 111 outcomes, ‘symptoms’ 109, ‘life impacts’ 30, ‘clinical signs’ 88, ‘clinical measurement’ 184, ‘performance of the intervention’ 58, ‘resource use’ 52 and ‘adverse events’ 190. Conclusion: The scoping review identified a large number of outcomes (n = 822) across 11 related outcome domains, supporting the need for a core outcome set.
KW - Core outcome set
KW - Randomised controlled trials
KW - Scoping review
KW - Venous leg ulceration
UR - https://www.scopus.com/pages/publications/85136748974
U2 - 10.1016/j.jtv.2022.07.013
DO - 10.1016/j.jtv.2022.07.013
M3 - Review article
C2 - 35973923
AN - SCOPUS:85136748974
SN - 0965-206X
VL - 31
SP - 751
EP - 760
JO - Journal of Tissue Viability
JF - Journal of Tissue Viability
IS - 4
ER -